Browsing Tag
Nemluvio
3 posts
Inside Galderma’s blockbuster Q3: Why EQT cashed out CHF690m amid record dermatology growth
Find out why EQT exited CHF 690 million in Galderma shares as the dermatology major raised full-year growth guidance after strong Q3 results.
Galderma’s Nemluvio gains FDA nod for moderate-to-severe atopic dermatitis
Galderma has achieved a significant milestone with the U.S. Food and Drug Administration’s (FDA) approval of Nemluvio (nemolizumab)…
Galderma’s breakthrough drug Nemluvio gains rapid FDA approval for severe itch condition
Galderma has achieved a significant milestone with the U.S. Food and Drug Administration (FDA) approving Nemluvio (nemolizumab) for…